← Back
$ONC All transactions

BeOne Medicines Ltd.

▼ SELL

$ Value

$804K

Shares

3,074

Price

$262

Filed

Jun 25

Insider

Name

OYLER JOHN

Title

Chief Executive Officer

CIK

0001042047

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-23

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

100

Footnotes

These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership. | These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. | These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. | These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account. | These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership. | Each American Depositary Share represents 13 Ordinary Shares | The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon change of control or certain termination events.

Filing Info

Accession No.

0001651308-25-000115

Form Type

4

Issuer CIK

0001651308

OYLER JOHN's History

Date Ticker Type Value
2026-03-06 ONC A $0
2026-03-06 ONC A $0
2025-12-16 ONC $565K
2025-12-16 ONC $181K
2025-12-16 ONC $775K
2025-12-16 ONC $457K
2025-12-16 ONC $2.3M
2025-12-16 ONC $495K
2025-12-16 ONC $1.7M
2025-12-16 ONC $382K

Other Insiders at ONC (90d)

Insider Bought Sold Last
OYLER JOHN
Chief Executive Officer
2026-03-06
Wu Xiaobin
President and COO
2026-03-06
Wang Lai
President, Global Head of R&D
2026-03-06
Lee Chan Henry
SVP, General Counsel
$786K 2026-04-08
Rosenberg Aaron
Chief Financial Officer
2026-03-06